Mymetics Corp (MYMX)

[Work Harder]

MilliporeSigma Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

20 MAY 2019

The effort will provide vaccine process development training courses within TRANSVAC2, a collaborative infrastructure project under Horizon 2020.

https://www.emdgroup.com/en/news/transvac2-program-joining-20-05-2019.html

“Involvement in this project is a natural extension to our longtime focus on accelerating vaccine development and manufacturing,” said Udit Batra, CEO, MilliporeSigma. “Through the TRANSVAC2 initiative, we are able to lend our expertise in vaccine research and development in this critically important field.”

MilliporeSigma’s focus, to find effective ways to accelerate vaccine development and manufacturing, includes collaborative work with leading research institutes and industries to introduce new technologies that advance the global vaccine industry. For this initiative, MilliporeSigma is tapping its internal manufacturing expertise and process knowledge in viral vaccines and vectors.

Weill